Skip to content

Katherine Altman, DO

NPI 1760877971ActiveIndividual· Internal Medicine· Seattle, WA

Internal Medicine (DO) in Seattle, Washington, licensed in WA, with an NPI issued in April 2015. Part D covered 3,523 prescriptions written in 2024. Glaxosmithkline, LLC. reported $119.11 in payments in 2025, mostly food and beverage.

Overview

NPI1760877971
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedApr 3, 2015
Last updated in NPPESApr 1, 2021
Certified by providerApr 1, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XOP60780374WA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (WA)

Part D prescriptions in 2024

Prescriptions (claims)3,523 · 3,529 30-day fills
Patients3,095
Total drug cost$655,392

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$119.11 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Glaxosmithkline, LLC.$119.111

What the 2025 payments were for

  • Food and Beverage$119.11 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Seattle

All Internal Medicine providers in Washington →